Status:
COMPLETED
Effects of Olive Oil and MLCT on Glycolipid Homeostasis in Patients With Metabolic Syndrome
Lead Sponsor:
Zhejiang University
Conditions:
Hyperlipidaemia
Metabolic Syndrome
Eligibility:
All Genders
40-70 years
Phase:
NA
Brief Summary
The type of cooking oil used is a crucial factor influencing dietary quality. The purpose of this study is to investigate the effects of olive oil and MLCT oil intervention on glucose and lipid homeos...
Detailed Description
We conducted a 6-month RCT to evaluate the effects of olive oil and MLCT as cooking oils on glucose and lipid homeostasis in patients with MetS; investigate the changes in lipoprotein subfractions and...
Eligibility Criteria
Inclusion
- Participants eligible for the study were those with a confirmed MetS diagnosis according to the IDF criteria53, aged between 40 and 70, and who reported infrequent consumption of meals outside the home (≤3 times per week)
Exclusion
- (i) current breastfeeding or pregnancy; (ii) history of cardiovascular disease, including heart disease, coronary artery disease, stroke, cerebral infarction, viral hepatitis (e.g., hepatitis A or B), chronic kidney disease (estimated glomerular filtration rate \[GFR\] \<60 ml/min), or malignancy; (iii) presence of diabetic ketoacidosis or hyperketonemia; (iv) recent alterations in prescribed medication within the previous 6 months; (v) current use of insulin therapy; (vi) consumption of MLCT in the preceding 6 months; (vii) participation in other clinical research studies within the last 6 months; and (viii) premenopausal women
Key Trial Info
Start Date :
June 9 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 22 2023
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT05233917
Start Date
June 9 2023
End Date
December 22 2023
Last Update
November 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lanxi Hospital of Traditional Chinese Medicine
Jinhua, Zhejiang, China